162 related articles for article (PubMed ID: 26136407)
1. Optimal management of cervical cancer in HIV-positive patients: a systematic review.
Ntekim A; Campbell O; Rothenbacher D
Cancer Med; 2015 Sep; 4(9):1381-93. PubMed ID: 26136407
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
3. Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era.
De Felice F; Di Mino A; Grapulin L; Mistrulli ML; Musio D; Tombolini V
Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3735-3739. PubMed ID: 28702826
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cervical cancer in HIV-seropositive women from developing countries: a protocol for a systematic review.
Mapanga W; Chipato T; Feresu SA
Syst Rev; 2018 Jan; 7(1):22. PubMed ID: 29370853
[TBL] [Abstract][Full Text] [Related]
5. Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.
Oehler-Jänne C; Seifert B; Lütolf UM; Ciernik IF
Radiat Oncol; 2006 Aug; 1():29. PubMed ID: 16916475
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review.
Mapanga W; Singh E; Feresu SA; Girdler-Brown B
Syst Rev; 2020 Apr; 9(1):79. PubMed ID: 32276672
[TBL] [Abstract][Full Text] [Related]
7. Effect of HIV serological status on outcome in patients with cancer of cervix treated with radiotherapy.
Kigula-Mugambe JB; Kavuma A
East Afr Med J; 2006 Aug; 83(8):416-23. PubMed ID: 17153654
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol.
Mapanga W; Elhakeem A; Feresu SA; Maseko F; Chipato T
Syst Rev; 2017 Apr; 6(1):91. PubMed ID: 28438187
[TBL] [Abstract][Full Text] [Related]
9. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
[TBL] [Abstract][Full Text] [Related]
11. Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
Simonds HM; Botha MH; Neugut AI; Van Der Merwe FH; Jacobson JS
Gynecol Oncol; 2018 Nov; 151(2):215-220. PubMed ID: 30194006
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
13. HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
Simonds HM; Neugut AI; Jacobson JS
Int J Gynecol Cancer; 2015 Jun; 25(5):884-90. PubMed ID: 25853380
[TBL] [Abstract][Full Text] [Related]
14. Management of cervical neoplasia.
Robinson W
Cancer Treat Res; 2001; 104():287-302. PubMed ID: 11227083
[No Abstract] [Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL CANCER IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract][Full Text] [Related]
17. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience.
Martellotta F; Berretta M; Cacopardo B; Fisichella R; Schioppa O; Zanghì A; Spartà D; Cappellani A; Talamini R; Izzi I; Ridolfo A; Torresin A; Fiorica F; Tirelli U
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1283-91. PubMed ID: 23047514
[TBL] [Abstract][Full Text] [Related]
19. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature.
Hill S; Kavookjian J
AIDS Care; 2012; 24(5):583-92. PubMed ID: 22292452
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening issues for HIV positive women: a physician's perspective.
Bardaro L
BETA; 1996 Jun; ():35-8. PubMed ID: 11363648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
